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ABSTRACT 
Objective: Synthesis, characterization and antimicrobial evaluation of some new 1,3-benzothiazolyl pyrazole derivatives. 
Methods: Aseries of novel2-[3-(substituted phenyl)-4-formylpyrazol-1-yl]-6-chloro benzothiazole derivatives (5a-g) have been synthesized by 
cyclization through Vilsmeier-Haack reaction on hydrazones (4a-g)of substituted aromatic ketones with 6-chloro benzothiazol-2-yl hydrazine under 
microwave irradiation in fairly good yields. All the newly synthesized compounds were characterized by IR, 1
Results: The results revealed that all 1,3-benzothiazole pyrazole derivatives(5a-g) were synthesized in satisfactory yields and pharmacologically 
evaluated for their in vitro antimicrobial activity. All the synthesized compounds were in good agreement with elemental and spectral data. Some of 
the tested compounds showed good to moderate antimicrobial activity against all tested pathogenic bacterial and fungal strains. 
HNMR, Mass spectral studies and 
elemental analysis and were screened for their in vitro antibacterial and antifungal activities also. 
Conclusion: For the present investigation we have prepared benzothiazole derivatives that are incorporated with pyrazolyl moiety with the hope of 
potentiating the activity of two such units in the same compound. Compounds 5b, 5c, and 5a showed excellent antibacterial and antifungal activities 
as compared to reference drugs norfloxacin and ketoconazole. 
Keywords: Benzothiazole, Antibacterial activity, Antifungal activity, Pyrazole. 
 
INTRODUCTION 
It is an established fact that benzothiazole derivatives contain extended 
p-delocalized systems which are capable of binding to DNA molecules 
via p–p interactions and therefore exhibited various biological 
properties like antitumor, antimicrobial and anthelmintic activities [1]. 
Benzothiazoles comprise a novel class of therapeutic compounds found 
to possess a number of biological activities such as anticancer [2-3], anti-
inflammatory [4], antimicrobial [5-6], antidiabetic [7], antiviral [8] and 
antileishmanial [9]. Therefore from the above facts, we herein report the 
synthesis of some new formylated pyrazolyl benzothiazole derivatives 
with the hope of finding of potent antibacterial and antifungal 
compounds as the need of emergence due to the phenomenon of 
bacterial resistance of antimicrobial agents. 
MATERIALS AND METHODS 
All the newly synthesized compounds gave moderate to good yields. 
The homogeneity of synthesized compounds was ascertained by thin 
layer chromatography (TLC) on silica gel G (Merck) coated plates by 
using different solvent systems. The visualization was done by using 
iodine vaporus and UV light chamber. The chemicals and solvents used 
for experimental work were commercially procured from CDH,E. 
Merck, S. D. fine chem. and Qualigens. The silica gel G used for 
analytical chromatography was obtained from E. Merck. Melting points 
were determined in open glass capillary tubes in a Hicon melting 
apparatus and are uncorrected. IR spectra were recorded in KBr 
pellets on JASCO FT-IR 410 spectrophotometer. The 1
Experimental 
HNMR spectra 
was recorded downfield on VNMRS-500 “Agilent-NMR” using (TMS) 
tetramethyl silane as an internal standard. The chemical shift are 
reported in ppm δ scale. LCMS Mass spectra were recorded on 
MASPEC low resolution mass spectrometer at an ionization potential 
of 70eV. The elemental analyses (C, H, and N) of all compounds were 
performed and the measured values agreed within calculated ones.  
Synthesis of 6-chloro-2-benzothiazolamine (2) 
General procedure 
A mixture of p-chloroaniline (0.01 mol) and potassium thiocyanate 
(0.01 mol) in 150 ml glacial acetic acid (10 %) was cooled and 
stirred mechanically for 30 min at 2-4 ºC. To this solution bromine 
(0.01 mol, 1.6 ml in 6 ml glacial acetic acid) was added drop wise at 
such a rate to keep the temperature of the solution below 10ºC 
throughout the addition. After all the bromine was added (105 min), 
stirring was continued for an additional 6 h at room temperature. The 
precipitate of hydrochloric salt of benzothiazole was filtered, washed 
with acetic acid and dried. Separated hydrochloric salt was dissolved 
in hot water and neutralized with aqueous ammonia solution (25 %), 
filtered, washed with water, dried and recrystallized with benzene to 
obtain 6-chloro-2-benzothiazolamine (2). 
Yield: 73 %; m. p. 209-211 °C; IR (KBr, cm-1
612 (C-S-C, benzothiazole), 1080 (C-Cl, benzothiazole);
): 3410 (N-H), 3080 (CH-
Ar), 1580 (C=N), 1280 (C-N),  
1HNMR (300 
MHz, DMSO-d6 , δ ppm): 6.78-6.70 (m, 3H, Ar-H), 7.14 (s, 2H, NH2, 
D2O exchangeable); MS (m/z): 183 [M+]; Anal. Calcd. for C7H5ClN2
Synthesis of 6-chlorobenzothiazol-2-yl-hydrazine (3) 
S: 
C, 45.53 %; H, 2.73 %; N, 15.17 %. Found: C, 45.52 %; H, 2.70 %; N, 
15.15 %. 
General procedure 
In a flat bottomed flaskconc. HCl (6 ml) was added drop wise with 
stirring to hydrazine hydrate (99 %, 6 ml) at 5-10 ºC. To it ethylene 
glycol (24 ml) and compound (2) (0.03 mol) were added in portions 
and refluxed for 3 h. On cooling white solid separate out, which was 
filtered, washed with water and recrystallized from ethanol (3). 
Yield: 82 %; m. p. 220-224 °C; IR (KBr, cm-1): 3330 (N-H), 3015 (CH-
Ar), 1462 (C=N),1250 (C-N), 690 (C-S-C, benzothiazole), 970 (C-Cl, 
benzothiazole);1HNMR(300 MHz, DMSO-d6 , δ ppm): 4.93 (s, 2H, 
NH2), 9.12 (s, 1H,-NHN, D2O exchangeable), 7.12-6.92 (m, 3H, Ar-H); 
MS (m/z): 199 [M+]; Anal. Calcd. for C7H6ClN3
Synthesis of 6-chlorobenzothiazol-2-yl-hydrazones (4a-g) 
S: C, 42.11 %; H, 3.03 
%; N, 21.05 %. Found: C, 42.13 %; H, 3.05 %; N, 21.07 %. 
General procedure 
A mixture of 6-chlorobenzothiazole-2-yl hydrazine (3) (1.5 mmol) 
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and appropriate aromatic ketones(2.2 mmol) in absolute ethanol 
(60 ml) containing glacial acetic acid (4-5 drops) was taken and 
refluxed for 5-13 h on water bath. (Till a different spot on TLC may 
appear).  
On cooling solid separated out, which was filtered, washed with little 
water and recrystallized from absolute alcohol to get hydrazones (4a-g). 
6-chloro-2-(-2-[1-(4-chlorophenyl)ethylidene]hydrazinyl)-1,3-
benzothiazole (4a) 
Yield: 56 %; m. p. 175-177 °C; IR (KBr, cm-1): 3356 (N-H), 1622 
(C=N),1254 (C-N), 680 (C-S-C, benzothiazole), 1004 (C-Cl, 
benzothiazole); 1HNMR(300 MHz, DMSO-d 6 , δ ppm): 4.52 (s, 
1H, NH), 2.32 (s, 3H, CH 3 -C=N-, D 2 O exchangeable), 6.84-7.12 
(m, 3H, Ar-H);MS (m/z): 336 [M+]; Anal. Calcd. for 
C 15 H 11 Cl 2N 3
2-(-2-[1-(4-bromophenyl) ethylidene]hydrazinyl)-6-chloro-1,3-
benzothiazole (4b) 
S: C, 53.61 %; H, 3.02 %; N, 12.50 %. Found: C, 
53.70 %; H, 3.07 %; N, 12.40 %. 
Yield: 58 %; m. p. 148-150 °C; IR (KBr, cm-1): 3256 (N-H), 1592 
(C=N),1258 (C-N), 698 (C-S-C), 570 (C-Br); 1HNMR(300 MHz, DMSO-
d6 , δ ppm): 4.42 (s, 1H, NH, D2O exchangeable), 2.30 (s, 3H, CH3-




S: C, 42.11 %; H, 3.03 %; N, 21.05 %. Found: C, 42.17 
%; H, 3.15 %; N, 21.17 %. 
Yield: 62 %; m. p. 182-184 °C; IR (KBr, cm-1): 3368 (N-H), 1632 
(C=N), 1144 (C-N), 587 (C-S-C), 1320 (C-NO2); 1HNMR(300 MHz, 
DMSO-d6 , δ ppm): 4.38 (s, 1H, NH, D2O exchangeable), 2.33 (s, 3H, 




S: C, 51.95 %; H, 3.20 %; N, 16.16 %. Found: C, 
51.96 %; H, 3.26; % N, 16.26%. 
Yield: 45 %; m. p. 194-196 °C; IR (KBr, cm-1): 3275 (N-H), 1643 
(C=N),1056 (C-N), 602 (C-S-C), 3400 (OH); 1HNMR(300 MHz, DMSO-
d6 , δ ppm): 4.38 (s, 1H, NH, D2O exchangeable), 2.33 (s, 3H, CH3-
C=N-), 7.82-8.12 (m, 3H, Ar-H) 10.2 (s, 1H, Ar-OH);MS (m/z): 317 
[M+]; Anal. Calcd. for C15H12ClN3
6-chloro-2-(-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl)-
1,3-benzothiazole (4e) 
OS: C, 56.69 %; H, 3.81 %; N, 13.22 
%. Found: C, 56.75 %; H, 3.85 %; N, 13.34 %. 
Yield: 53 %; m. p. 138-140 °C; IR (KBr, cm-1): 3368 (N-H), 1582 
(C=N),1214 (C-N), 684 (C-S-C); 1HNMR(300 MHz, DMSO-d6 , δ ppm): 
4.48 (s, 1H, NH, D2O exchangeable), 2.40 (s, 3H, CH3-C=N-), 7.62-




OS: C, 57.93 %; H, 4.25%; N, 12.66% Found: C, 
58.05%; H, 4.32 %; N, 12.72 %. 
Yield: 46 %; m. p. 210-212 °C; IR (KBr, cm-1): 3320 (N-H), 1618 
(C=N),1068 (C-N), 670 (C-S-C), 1234 (C-F); 1HNMR(300 MHz, DMSO-
d6 , δ ppm): 4.28 (s, 1H, NH, D2O exchangeable), 2.26 (s, 3H, CH3-




S: C, 56.34 %; H, 3.57 %; N, 13.14 %. Found: C, 56.42 %; 
H, 3.59 %; N, 13.23 %. 
Yield: 64 %; m. p. 200-202 °C; IR (KBr, cm-1): 3430 (NH2), 3278 (N-
H), 1582 (C=N), 1172(C-N), 658 (C-S-C); 1HNMR (300MHz, DMSO-d6 , 
δ ppm): 4.32 (s, 1H, NH, D2O exchangeable), 2.38 (s, 3H, CH3-C=N-), 
7.78-8.20 (m, 3H, Ar-H), 3.20 (s, 2H, NH2); MS (m/z): 317 [M+]; Anal. 
Calcd. for C15H13ClN4
Synthesis of 2-[3-(4-substitutedphenyl)-4-formyl-pyrazol-1-yl]-
6-chloro benzothiazoles (5a-g) 
S: C, 56.91 %; H, 4.14 %; N, 17.68 %. Found: C, 
56.86 %; H, 4.22 %; N, 17.70 %. 
General procedure 
To the Vilsmeier-Haack reagent prepared from DMF (10 ml) and 
POCl3 (1.1 ml, 12 mmol), hydrazone(4 mmol) was added and the 
reaction mixture was irradiated in microwave oven for 45-120 s. 
After completion of the reaction each reaction mixture was poured 
into ice cold water. The solid that separated on neutralization with 




-EtOH to get final compound. By following similar procedures 
compounds (5a-g) were synthesized. 
Yield: 45 %; m. p. 180-183 °C; IR (KBr, cm-1): 1720 (C=O), 2780, 
2878 (CH-Ar); 1HNMR(300 MHz, DMSO-d6 , δ ppm): 9.05 (s, 1H, 
pyrazole, D2O exchangeable), 9.95 (s, 1H, CHO), 7.54-7.52 (m, 3H, 
Ar-H), 7.94 (s, 2H, Ar-H), 8.06-8.03(m, 2H, Ar-H); MS (m/z): 373 
[M+]; Anal. Calcd. for C17H9Cl2N3
2-[3-(4-bromphenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5b) 
OS: C, 54.58 %; H, 2.44 %; N, 11.24 
% Found: C, 54.86; % H, 2.52 %; N, 11.30 %. 
Yield: 53 %; m. p. 197-200 °C; IR (KBr, cm-1): 1622 (C=O), 2770, 
2885 (CH-Ar); 1HNMR(300 MHz, DMSO-d6 , δ ppm): 9.02 (s, 1H, 
pyrazole, D2O exchangeable), 9.94 (s, 1H, CHO), 7.44-7.34(m, 3H, Ar-
H), 7.94 (s, 2H, Ar-H), 8.14-8.04(m, 2H, Ar-H); MS (m/z): 416 [M+]; 
Anal. Calcd. for C17H9ClBrN3
2-[3-(4-nitrophenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5c) 
OS: C, 48.77 %; H, 2.14 %; N, 10.06 %. 
Found: C, 48.86 %; H, 2.22 %; N, 10.15 %. 
Yield: 48 %; m. p. 230-232 °C; IR (KBr, cm-1): 1706 (C=O), 2710, 
2875(CH-Ar); 1HNMR(300 MHz,-DMSO-d6 , δ ppm): 9.10 (s, 1H, 
pyrazole, D2O exchangeable), 9.84 (s, 1H, CHO), 7.52-7.40 (m, 3H, 
Ar-H), 7.94 (s, 2H, Ar-H), 8.18-7.96 (m, 2H, Ar-H); MS (m/z): 385 
[M+]; Anal. Calcd. for C17H9ClN4SO3
2-[3-(4-hydroxyphenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5d) 
: C, 53.07 %; H, 2.38 %; N, 14.58 
%. Found: C, 53.16 %; H, 2.32 %; N, 14.70 %. 
Yield: 55 %; m. p. 178-180 °C; IR (KBr, cm-1): 1690 (C=O), 2768, 
2880 (CH-Ar); 1HNMR(300 MHz, DMSO-d6, δ ppm): 9.16(s, 1H, 
pyrazole, D2O exchangeable), 9.98 (s, 1H, CHO), 7.62-7.52 (m, 3H, 
Ar-H), 7.83 (s, 2H, Ar-H), 8.26-8.10 (m, 2H, Ar-H); MS (m/z): 355 
[M+]; Anal. Calcd. for C17H10ClN3SO2
2-[3-(4-methoxyphenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5e) 
: C, 57.40 %; H, 2.85 %; N, 11.85 
%. Found: C, 57.56 %; H, 2.92 %; N, 11.80 %. 
Yield: 56 %; m. p. 280-283 °C; IR (KBr, cm-1): 1712 (C=O), 2775, 
2876(C-H); 1HNMR (300 MHz, DMSO-d6 , δ ppm): 9.08 (s, 1H, 
pyrazole, D2O exchangeable), 9.95 (s, 1H, CHO), 7.72-7.68 (m, 3H, 
Ar-H), 7.98 (s, 2H, Ar-H), 7.98-7.86 (m, 2H, Ar-H); MS (m/z): 369 
[M+]; Anal. Calcd. for C18H12ClN3SO2
2-[3-(4-fluorophenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5f) 
: C, 58.46 %; H, 3.28 %; N, 11.38 
%. Found: C, 58.56 %; H, 3.26 %; N, 11.56 %. 
Yield: 49 %; m. p. 267-270 °C; IR (KBr, cm-1): 1708 (C=O), 2769, 
2803 (C-H); 1HNMR(300 MHz, DMSO-d6 , δ ppm): 9.04 (s, 1H, 
pyrazole, D2O exchangeable), 9.80 (s, 1H, CHO), 7.77-7.66 (m, 3H, 
Ar-H), 7.94 (s, 2H, Ar-H), 7.84-7.71 (m, 2H, Ar-H); MS (m/z): 357 
[M+]; Anal. Calcd. for C17H9ClFN3
2-[3-(4-aminophenyl)-4-formyl-pyrazol-1-yl]-6-chloro 
benzothiazole (5g) 
OS: C, 57.08 %; H, 2.56 %; N, 11.78 
%. Found: C, 57.16 %; H, 2.59 %; N, 11.85 %. 
Yield: 52 %; m. p. 146-150 °C; IR (KBr, cm-1): 1682 (C=O), 2786, 
2890(C-H); 1HNMR(DMSO-d6, δ ppm): 9.12 (s, 1H, pyrazole, D2O 
exchangeable), 9.95 (s, 1H, CHO), 7.79-7.68 (m, 3H, Ar-H), 7.94 (s, 
2H, Ar-H), 7.78-7.66 (m, 2H, Ar-H); MS (m/z): 355 [M+]; Anal. Calcd. 
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OS: C, 57.56 %; H, 3.14 %; N, 15.80 %. Found: C, 57.62 
%; H, 3.22 %; N, 15.75 %. 
 
 
Scheme 1: Reagents and Conditions (i) Glacial acetic acid, KSCN, 
Br2, Stirring 10 h (ii) NH2. NH2. H2O, ethylene glycol, reflux for 
3 h (iii) ethanol, reflux 5 h. (iv) DMF/POCl3
Antibacterial activity 
, MWI 
In vitro antibacterial activity of the synthesized compounds (5a-g) 
was examined against Gram positive bacteria [Staphylococcus aureus 
(ATCC-25923)] and Gram-negative bacteria [Escherichia coli (ATCC-
25922), Pseudomonas aeruginosa (ATCC-27853) and Klebsiella 
pneumoniae (MTCC-432)] by measuring zone of inhibition.  
The antibacterial activity was performed by disc diffusion method 
at the concentration level of 100 µg/ml. Norfloxacin was used as 
the standard drug at a concentration of 100 µg/ml. Nutrient agar 
was used as culture media and DMSO was used as the solvent 
control. The results of antibacterial activity of synthesized 
compounds are shown in table 1. 
Antifungal activity 
In vitro antifungal activity of the synthesized compounds (5a-g) was 
examined against Aspergillus niger (MTCC-281) and Candida 
albicans (ATCC 2099)by measuring the zone of inhibition. The 
antifungal activity was performed by disc diffusion method at the 
concentration level of 100 µg/ml. Ketoconazole was used as the 
reference drug for antifungal activity at the concentration level of 
100 µg/ml. Sabouraud dextrose agar was used as culture media and 
DMSO was used as the solvent control. The results of antifungal 
activity of synthesized compounds are shown in table 2. 
 
Table 1: Antibacterial activity of the title compounds (5a-g) 
Compound Inhibition rate a(%) 
S. aureus (ATCC-25923) E. coli (ATCC-25922) P. aeruginosa (ATCC-27853)  K. pneumoniae (MTCC-432) 
5a 72±1.6 80±0.9 75±3.5 71±1.9 
5b 89±1.7 80±1.2 88±3.8 94±1.0 
5c 94±2.9 93±2.5 94±2.8 94±1.2 
5d 44±0.9 53±1.1 50±1.6 53±0.9 
5e 50±2.4 60±1.2 63±1.9 59±2.6 
5f 39±2.7 53±3.2 50±2.2 53±3.2 
5g 50±3.9 53±2.4 56±3.4 53±3.8 
Norfloxacin 100±3.7 100±4.9 100±4.2 100±4.8 
a
 
Average of three replicates, MIC at 100 µg/ml 
Table 2: Antifungal activity of the title compounds (5a-g) 
Compound Inhibition rate a(%) 
A. niger (MTCC-281)  C. albicans (ATCC 2099)  
5a 79±2.3 80±1.4 
5b 86±3.6 80±1.8 
5c 93±4.4 93±2.2 
5d 57±1.8 53±2.7 
5e 57±2.6 60±3.1 
5f 71±3.8 60±4.2 
5g 64±5.1 67±3.7 
Ketoconazole 100±3.5 100±4.5 
a
 
Average of three replicates, MIC at 100 µg/ml 
RESULTS AND DISCUSSION 
The synthesis of various 2-[3-(4-substitutedphenyl)-4-formyl-
pyrazol-1-yl]-6-chloro benzothiazole derivatives (5a-g) was 
accomplished as presented in Scheme 1. It involves the cyclization of 
p-chloro amine and formation of compound (2), through KSCN then 
involves the reaction of hydrazine hydrate with compound (2) in the 
presence of ethylene glycol and formation of compounds (4a-g) 
through reaction of different methyl phenyl ketones in the presence 
of ethanol and compound (3) by refluxing for 6 h.  
Then Vilsmeier Haack reaction was applied to benzothiazole 
hydrazones (4a-g) under MWI for 45-120 s to obtain corresponding 
formylated pyrazolyl benzothiazoles (5a-g)in fairly good yields. The 
structures of all the new synthesized compounds have been 
confirmed through their elemental analysis, IR and 1HNMR, and 
mass spectra. The IR spectra exhibited a strong characteristic band 
in the region 1690-1720 cm-1 due to C=O (str.), and a weak band in 
the region 2730-2785 cm-1 due to C-H (str.) of the aldehyde group 
present in the pyrazole ring while their 1HNMR spectra showed two 
sharp singlets at δ 9.05 and δ 9.95 confirmed the presence of C5-H of 
the pyrazole ring and C-H of the C4-aldehyde group respectively. The 
synthesized compounds were evaluated for their anti-bacterial 
activity against S. aureus, E. coli, P. aeruginosa and K. pneumoniae 
and anti-fungal activity against A. niger and C. albicans. 
TheCompounds 5c, 5b, 5a, showed excellent anti-bacterialand 
antifungal activity due to substitution of electron withdrawing 
groups (Cl, Br, NO2) on 4-position of phenyl ring while the activity is 
sharply decreased by the substitution of electron donating (OCH3, 
NH2, OH) groups at 4-position of phenyl ring. Compounds 5c, 5b, 5a 
were also found to have good activity againstA. niger and C. albicans. 
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Herein, we have described an efficient and convenient synthesis of a 
new series of 2-[3-(substituted phenyl)-4-formylpyrazol-1-yl]-6-
chloro benzo thiazole derivatives (5a-g). The structures of these new 
heterocyclic compounds containing both aminobenzo thiazole and 
pyrazole ring systems were confirmed by spectral (IR, 1
1. Pavlovic G, Soldin Z, Popovic Z, Kulenovic VT. Synthesis and 
characterization of mercury (II) complexes with 2-styryl-1,3-
benzothiazole (sb). Presence of two differently coordinated Hg 
(II) ions in the dinuclear complex Hg2Cl4(sb)3. Structural 
HNMR, 
Mass) and elemental analysis (C, H, N) analysis and were evaluated 
for their in vitro antibacterial and antifungal activities. The 
compounds with electron withdrawing groups on 6-position of 
benzothiazole ring and 4-position of the phenyl ring showed 
excellent antibacterial and antifungal activities. Thus, the significant 
antibacterial and antifungal profiles of 6-chloro-1,3-benzothiazolyl-
2-yl pyrazole derivatives offer as promising lead molecules for 
further synthesis of potent compounds of this series. 
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